These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29713950)

  • 1. Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary.
    Nord E; Lamøy C
    Pharmacoecon Open; 2018 Dec; 2(4):357-358. PubMed ID: 29713950
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance.
    Holmes EAF; Hughes DA
    Antibiotics (Basel); 2019 Sep; 8(4):. PubMed ID: 31569624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health impact and economic burden of alcohol consumption in India.
    Jyani G; Prinja S; Ambekar A; Bahuguna P; Kumar R
    Int J Drug Policy; 2019 Jul; 69():34-42. PubMed ID: 31055044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-of-Life Care Interventions: An Economic Analysis.
    Pham B; Krahn M
    Ont Health Technol Assess Ser; 2014; 14(18):1-70. PubMed ID: 26339303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECONOMIC EVALUATION STUDIES OF SELF-MANAGEMENT INTERVENTIONS IN CHRONIC DISEASES: A SYSTEMATIC REVIEW.
    van Eeden M; van Heugten CM; van Mastrigt GA; Evers SM
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):16-28. PubMed ID: 27125195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On future non-medical costs in economic evaluations.
    Liljas B; Karlsson GS; Stålhammar NO
    Health Econ; 2008 May; 17(5):579-91. PubMed ID: 17787027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?
    Karnon J; Partington A
    Pharmacoeconomics; 2015 Dec; 33(12):1281-8. PubMed ID: 26100285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age structure and capital dilution effects in neo-classical growth models.
    Blanchet D
    J Popul Econ; 1988; 1(3):183-94. PubMed ID: 12315988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meat consumption reduction in Italian regions: Health co-benefits and decreases in GHG emissions.
    Farchi S; De Sario M; Lapucci E; Davoli M; Michelozzi P
    PLoS One; 2017; 12(8):e0182960. PubMed ID: 28813467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review.
    Farbman L; Avni T; Rubinovitch B; Leibovici L; Paul M
    Clin Microbiol Infect; 2013 Dec; 19(12):E582-93. PubMed ID: 23991635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the sustainability of tin in China.
    Yang C; Tan Q; Zeng X; Zhang Y; Wang Z; Li J
    Sci Total Environ; 2018 Sep; 635():1351-1359. PubMed ID: 29710588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting the health and economic impact of road safety initiatives: a case study of a multi-country project.
    Esperato A; Bishai D; Hyder AA
    Traffic Inj Prev; 2012; 13 Suppl 1():82-9. PubMed ID: 22414132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsimulation model for the health economic evaluation of osteoporosis interventions: study protocol.
    Si L; Eisman JA; Winzenberg T; Sanders KM; Center JR; Nguyen TV; Palmer AJ
    BMJ Open; 2019 Feb; 9(2):e028365. PubMed ID: 30782956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial based economic evaluation of occupational therapy discharge planning for older adults: the HOME randomized trial.
    Wales K; Salkeld G; Clemson L; Lannin NA; Gitlin L; Rubenstein L; Howard K; Howell M; Cameron ID
    Clin Rehabil; 2018 Jul; 32(7):919-929. PubMed ID: 29569470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation in healthcare. A brief history and future directions.
    Blumenschein K; Johannesson M
    Pharmacoeconomics; 1996 Aug; 10(2):114-22. PubMed ID: 10163414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.
    Krauth C; Jalilvand N; Welte T; Busse R
    Pharmacoeconomics; 2003; 21(14):1001-24. PubMed ID: 13129414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the economic and environmental sustainability of household food waste management in the UK: Current situation and future scenarios.
    Slorach PC; Jeswani HK; Cuéllar-Franca R; Azapagic A
    Sci Total Environ; 2020 Mar; 710():135580. PubMed ID: 31785911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.